Mechanism of Action
Unsiatem® is a Xanthine Oxidase (XO) inhibitor
– Unsiatem® inhibits both the oxidized and reduced form of XO
– Unsiatem® is a non-purine, selective and potent inhibitor of XO, 10-30 times more than allopurinol, and has no effect on other enzymes involved in purine or pyrimidine metabolism
Unsiatem 40 & 80mg: chronic management of hyperuricemia in patients with gout.
Unsiatem 120mg: management of hyperuricemia associated with tumor lysis syndrome.
Unsiatem® 40mg Once Daily
Unsiatem® 80mg Once Daily
Starting Unsiatem 120mg 2 days before induction chemotherapy, for 7-9 days.
Unsiatem® 40mg/ 80mg/ 120mg
The carton box contains 3 strips: Each one contains 10 film-coated tablets & insert leaflet.